Search Results - "Beydağı, Gamze"

Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer by Kınıkoğlu, Oğuzcan, Öven, Bala Başak, Çelik, Serkan, Alan Selçuk, Nalan, Beydağı, Gamze, Akçay, Kaan, Kabasakal, Levent

“…The combination of Lutetium-177 (Lu-177) PSMA-617 radioligand therapy (RLT) with androgen receptor pathway inhibitors (ARPIs) has shown promise in metastatic…”
Get full text

Revision of the Histopathological Examination Following 68Ga- DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis by Alan Selçuk, Nalan, Akçay, Kaan, Beydağı, Gamze, Sönmez, Ömer, Çelik, Serkan, Öven, Bala Başak, Kabasakal, Levent

“…Neuroendocrine tumors (NETs) of the breast represent 1% of breast carcinomas. Histopathological misinterpretation of breast NET is common. We present the case…”
Get full text

Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors by Demirci, Emre, Alan Selçuk, Nalan, Beydağı, Gamze, Ocak, Meltem, Toklu, Türkay, Akçay, Kaan, Kabasakal, Levent

“…ObjectivesThis study aimed to evaluate the stability, safety, and efficacy of alpha-targeted therapy with [225Ac]Ac-DOTATATE in patients with grade 1/2…”
Get full text

Revision of the Histopathological Examination Following 68 Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis by Alan Selçuk, Nalan, Akçay, Kaan, Beydağı, Gamze, Sönmez, Ömer, Çelik, Serkan, Öven, Bala Başak, Kabasakal, Levent

“…Neuroendocrine tumors (NETs) of the breast represent 1% of breast carcinomas. Histopathological misinterpretation of breast NET is common. We present the case…”
Get full text

Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance by Akcay, Kaan, Kibar, Ali, Sahin, Onur Erdem, Demirbilek, Muhammet, Beydagi, Gamze, Asa, Sertac, Aghazada, Fuad, Toklu, Turkay, Selcuk, Nalan Alan, Onal, Bulent, Kabasakal, Levent

“…Purpose In our study, our aim was to investigate the role of [ 68  Ga]Ga-PSMA-11 PET /CT imaging in the diagnosis of clinically significant prostate cancer…”
Get full text

Clinical Experience with [ 225 Ac]Ac-PSMA Treatment in Patients with [ 177 Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer by Alan-Selcuk, Nalan, Beydagi, Gamze, Demirci, Emre, Ocak, Meltem, Celik, Serkan, Oven, Bala B., Toklu, Turkay, Karaaslan, Ipek, Akcay, Kaan, Sonmez, Omer, Kabasakal, Levent

“…For patients with advanced-stage metastatic castration-resistant prostate cancer (mCRPC) who do not respond to [177Lu]Lu-PSMA therapy, there are limited…”
Get full text

Prediction of clinically significant prostate cancer by 68 GaGa-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance by Akcay, Kaan, Kibar, Ali, Sahin, Onur Erdem, Demirbilek, Muhammet, Beydagi, Gamze, Asa, Sertac, Aghazada, Fuad, Toklu, Turkay, Selcuk, Nalan Alan, Onal, Bulent, Kabasakal, Levent

“…In our study, our aim was to investigate the role of [68 Ga]Ga-PSMA-11 PET /CT imaging in the diagnosis of clinically significant prostate cancer (csPCa) (ISUP…”
Get full text

Revision of the Histopathological Examination Following [.sup. Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis by Selcuk, Nalan Alan, Akcay, Kaan, Beydagi, Gamze, Sonmez, Omer, Celik, Serkan, Oven, Bala Basak, Kabasakal, Levent

“…Neuroendocrine tumors (NETs) of the breast represent 1% of breast carcinomas. Histopathological misinterpretation of breast NET is common. We present the case…”
Get full text